|
THNSL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58060239843871E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.07349750889352E-11 |
| Normal-vs-Stage2 |
2.65069999949574E-07 |
| Normal-vs-Stage3 |
9.55370005328859E-09 |
| Normal-vs-Stage4 |
3.77559999999999E-05 |
| Stage1-vs-Stage2 |
6.908600E-01 |
| Stage1-vs-Stage3 |
4.698600E-01 |
| Stage1-vs-Stage4 |
9.307200E-01 |
| Stage2-vs-Stage3 |
8.464400E-01 |
| Stage2-vs-Stage4 |
7.305000E-01 |
| Stage3-vs-Stage4 |
5.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.60913554387344E-12 |
| Normal-vs-AfricanAmerican |
3.45469985951752E-10 |
| Normal-vs-Asian |
1.463830E-03 |
| Caucasian-vs-AfricanAmerican |
9.561600E-01 |
| Caucasian-vs-Asian |
7.339800E-01 |
| AfricanAmerican-vs-Asian |
7.098400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01327843285526E-12 |
| Normal-vs-Female |
1.17349999717575E-08 |
| Male-vs-Female |
5.012000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.8745999438089E-10 |
| Normal-vs-Extreme_Weight |
1.97097893561704E-12 |
| Normal-vs-Obese |
3.74300002103922E-09 |
| Normal-vs-Extreme_Obese |
4.770200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.261000E-01 |
| Normal_Weight-vs-Obese |
4.706400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.350000E-01 |
| Extreme_Weight-vs-Obese |
2.116800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.922000E-02 |
| Obese-vs-Extreme_Obese |
3.189800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.76219999948569E-07 |
| Normal-vs-Age(41-60Yrs) |
1.66939995160931E-09 |
| Normal-vs-Age(61-80Yrs) |
2.9322100303375E-12 |
| Normal-vs-Age(81-100Yrs) |
3.14869996742573E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.716400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.514800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.759500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.632200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.312100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.628240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.27189403243256E-12 |
| Normal-VS-Type2 PRCC |
7.30430005368987E-09 |
| Normal-VS-KIRP CIMP |
7.91380000420006E-08 |
| Normal-VS-Unclassified PRCC |
2.55919951896999E-10 |
| Type1 PRCC-VS-Type2 PRCC |
7.508800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.961700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.697600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.312760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.939000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.966560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7414003572469E-10 |
| Normal-vs-N1 |
9.78980000398977E-08 |
| Normal-vs-N2 |
6.0618999999984E-05 |
| N0-vs-N1 |
9.611200E-01 |
| N0-vs-N2 |
4.499600E-01 |
| N1-vs-N2 |
4.798400E-01 |
|
|
